APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antidiarrheal Microorganisms

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antidiarrheal Microorganisms Industry Growth and Trends Forecast to 2032

Report ID 173966110127 December 2025110 pages

Choose your research edition.

Industry ResearchAntidiarrheal Microorganisms Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Antidiarrheal Microorganisms Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Antidiarrheal Microorganisms Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antidiarrheal Microorganisms Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Antidiarrheal Microorganisms Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Antidiarrheal Microorganisms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antidiarrheal Microorganisms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antidiarrheal Microorganisms include Zhejiang Jingxin Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., Livzon Pharmaceutical Factory of Livzon Group, Sinovac Biotech Co., Ltd., Jincheng Haisi Pharmaceutical Co., Ltd., Hangzhou Yuanda Biopharmaceutical Co., Ltd., Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. and Beijing Hanmei Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antidiarrheal Microorganisms market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antidiarrheal Microorganisms market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antidiarrheal Microorganisms market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antidiarrheal Microorganisms.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antidiarrheal Microorganisms market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antidiarrheal Microorganisms Market by Company

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Shanghai SPH Xinyi Pharmaceutical Co., Ltd.

Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.

Livzon Pharmaceutical Factory of Livzon Group

Sinovac Biotech Co., Ltd.

Jincheng Haisi Pharmaceutical Co., Ltd.

Hangzhou Yuanda Biopharmaceutical Co., Ltd.

Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.

Beijing Hanmei Pharmaceutical Co., Ltd.

VWR

Vermicon AG

Tangsonsbio

Pepto Bismol

Goerlich Pharma

Chr. Hansen

Biofermin

Aptalis Pharma SAS

Antidiarrheal Microorganisms Segment by Type

Bifidobacterium Live Bacteria

Bacillus Subtilis Live Bacteria

Bacillus Licheniformis Live Bacteria

Other

Antidiarrheal Microorganisms Segment by Application

Pharmacy

Hospital

Clinic

Other

Antidiarrheal Microorganisms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiarrheal Microorganisms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antidiarrheal Microorganisms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiarrheal Microorganisms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antidiarrheal Microorganisms manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antidiarrheal Microorganisms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Bifidobacterium Live Bacteria Table 2. Major Company of Bacillus Subtilis Live Bacteria Table 3. Major Company of Bacillus Licheniformis Live Bacteria Table 4. Major Company of Other Table 5. Global Antidiarrheal Microorganisms Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 7. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Type (2021-2026) Table 8. Global Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 9. Global Antidiarrheal Microorganisms Sales Market Share in Value by Type (2021-2026) Table 10. Global Antidiarrheal Microorganisms Price by Type (2021-2026) & (US$/Unit) Table 11. Global Antidiarrheal Microorganisms Sales by Type (2027-2032) & (K Units) Table 12. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Type (2027-2032) Table 13. Global Antidiarrheal Microorganisms Sales by Type (2027-2032) & (US$ Million) Table 14. Global Antidiarrheal Microorganisms Sales Market Share in Value by Type (2027-2032) Table 15. Global Antidiarrheal Microorganisms Price by Type (2027-2032) & (US$/Unit) Table 16. North America Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 17. North America Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 19. Europe Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 23. Latin America Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Antidiarrheal Microorganisms Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Antidiarrheal Microorganisms Sales by Type (2021-2026) & (US$ Million) Table 26. Antidiarrheal Microorganisms Industry Trends Table 27. Antidiarrheal Microorganisms Industry Drivers Table 28. Antidiarrheal Microorganisms Industry Opportunities and Challenges Table 29. Antidiarrheal Microorganisms Industry Restraints Table 30. Global Antidiarrheal Microorganisms Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Antidiarrheal Microorganisms Revenue Market Share by Company (2021-2026) Table 32. Global Antidiarrheal Microorganisms Sales by Company (2021-2026) & (K Units) Table 33. Global Antidiarrheal Microorganisms Sales Share by Company (2021-2026) Table 34. Global Antidiarrheal Microorganisms Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Antidiarrheal Microorganisms Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Antidiarrheal Microorganisms Major Company Production Sites and Headquarters Table 37. Global Antidiarrheal Microorganisms Company, Product Type & Application Table 38. Global Antidiarrheal Microorganisms Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Antidiarrheal Microorganisms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Antidiarrheal Microorganisms Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Antidiarrheal Microorganisms Sales by Region (2021-2026) & (K Units) Table 43. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Region (2021-2026) Table 44. Global Antidiarrheal Microorganisms Sales by Region (2021-2026) & (US$ Million) Table 45. Global Antidiarrheal Microorganisms Sales Market Share in Value by Region (2021-2026) Table 46. Global Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Antidiarrheal Microorganisms Sales by Region (2027-2032) & (K Units) Table 48. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Region (2027-2032) Table 49. Global Antidiarrheal Microorganisms Sales by Region (2027-2032) & (US$ Million) Table 50. Global Antidiarrheal Microorganisms Sales Market Share in Value by Region (2027-2032) Table 51. Global Antidiarrheal Microorganisms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Antidiarrheal Microorganisms Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 54. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Application (2021-2026) Table 55. Global Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 56. Global Antidiarrheal Microorganisms Sales Market Share in Value by Application (2021-2026) Table 57. Global Antidiarrheal Microorganisms Price by Application (2021-2026) & (US$/Unit) Table 58. Global Antidiarrheal Microorganisms Sales by Application (2027-2032) & (K Units) Table 59. Global Antidiarrheal Microorganisms Sales Market Share in Volume by Application (2027-2032) Table 60. Global Antidiarrheal Microorganisms Sales by Application (2027-2032) & (US$ Million) Table 61. Global Antidiarrheal Microorganisms Sales Market Share in Value by Application (2027-2032) Table 62. Global Antidiarrheal Microorganisms Price by Application (2027-2032) & (US$/Unit) Table 63. North America Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 64. North America Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 66. Europe Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 70. Latin America Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Antidiarrheal Microorganisms Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Antidiarrheal Microorganisms Sales by Application (2021-2026) & (US$ Million) Table 73. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information Table 74. Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview Table 75. Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 77. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Development Table 78. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information Table 79. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview Table 80. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 82. Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Development Table 83. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information Table 84. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Business Overview Table 85. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 87. Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Recent Development Table 88. Livzon Pharmaceutical Factory of Livzon Group Company Information Table 89. Livzon Pharmaceutical Factory of Livzon Group Business Overview Table 90. Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolio Table 92. Livzon Pharmaceutical Factory of Livzon Group Recent Development Table 93. Sinovac Biotech Co., Ltd. Company Information Table 94. Sinovac Biotech Co., Ltd. Business Overview Table 95. Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 97. Sinovac Biotech Co., Ltd. Recent Development Table 98. Jincheng Haisi Pharmaceutical Co., Ltd. Company Information Table 99. Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview Table 100. Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 102. Jincheng Haisi Pharmaceutical Co., Ltd. Recent Development Table 103. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information Table 104. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Business Overview Table 105. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 107. Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Development Table 108. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information Table 109. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Business Overview Table 110. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 112. Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Recent Development Table 113. Beijing Hanmei Pharmaceutical Co., Ltd. Company Information Table 114. Beijing Hanmei Pharmaceutical Co., Ltd. Business Overview Table 115. Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio Table 117. Beijing Hanmei Pharmaceutical Co., Ltd. Recent Development Table 118. VWR Company Information Table 119. VWR Business Overview Table 120. VWR Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. VWR Antidiarrheal Microorganisms Product Portfolio Table 122. VWR Recent Development Table 123. Vermicon AG Company Information Table 124. Vermicon AG Business Overview Table 125. Vermicon AG Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Vermicon AG Antidiarrheal Microorganisms Product Portfolio Table 127. Vermicon AG Recent Development Table 128. Tangsonsbio Company Information Table 129. Tangsonsbio Business Overview Table 130. Tangsonsbio Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Tangsonsbio Antidiarrheal Microorganisms Product Portfolio Table 132. Tangsonsbio Recent Development Table 133. Pepto Bismol Company Information Table 134. Pepto Bismol Business Overview Table 135. Pepto Bismol Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Pepto Bismol Antidiarrheal Microorganisms Product Portfolio Table 137. Pepto Bismol Recent Development Table 138. Goerlich Pharma Company Information Table 139. Goerlich Pharma Business Overview Table 140. Goerlich Pharma Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Goerlich Pharma Antidiarrheal Microorganisms Product Portfolio Table 142. Goerlich Pharma Recent Development Table 143. Chr. Hansen Company Information Table 144. Chr. Hansen Business Overview Table 145. Chr. Hansen Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Chr. Hansen Antidiarrheal Microorganisms Product Portfolio Table 147. Chr. Hansen Recent Development Table 148. Biofermin Company Information Table 149. Biofermin Business Overview Table 150. Biofermin Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Biofermin Antidiarrheal Microorganisms Product Portfolio Table 152. Biofermin Recent Development Table 153. Aptalis Pharma SAS Company Information Table 154. Aptalis Pharma SAS Business Overview Table 155. Aptalis Pharma SAS Antidiarrheal Microorganisms Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolio Table 157. Aptalis Pharma SAS Recent Development Table 158. North America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. North America Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 160. North America Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 161. North America Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032) & (K Units) Table 162. North America Antidiarrheal Microorganisms Sales Market Share Forecast by Country (2027-2032) Table 163. North America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Antidiarrheal Microorganisms Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Antidiarrheal Microorganisms Market Share by Country (2021-2026) Table 166. North America Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Antidiarrheal Microorganisms Market Share Forecast by Country (2027-2032) Table 168. Europe Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 169. Europe Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 170. Europe Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 171. Europe Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032) & (K Units) Table 172. Europe Antidiarrheal Microorganisms Sales Market Share Forecast by Country (2027-2032) Table 173. Europe Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Antidiarrheal Microorganisms Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Antidiarrheal Microorganisms Market Share by Country (2021-2026) Table 176. Europe Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Antidiarrheal Microorganisms Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 180. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 181. Asia-Pacific Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032) & (K Units) Table 182. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Antidiarrheal Microorganisms Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Antidiarrheal Microorganisms Market Share by Country (2021-2026) Table 186. Asia-Pacific Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Antidiarrheal Microorganisms Market Share Forecast by Country (2027-2032) Table 188. Latin America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 189. Latin America Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 190. Latin America Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 191. Latin America Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032) & (K Units) Table 192. Latin America Antidiarrheal Microorganisms Sales Market Share Forecast by Country (2027-2032) Table 193. Latin America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Antidiarrheal Microorganisms Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Antidiarrheal Microorganisms Market Share by Country (2021-2026) Table 196. Latin America Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Antidiarrheal Microorganisms Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Antidiarrheal Microorganisms Sales by Country (2021-2026) & (K Units) Table 200. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share by Country (2021-2026) Table 201. Middle East and Africa Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032) & (K Units) Table 202. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Antidiarrheal Microorganisms Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East and Africa Antidiarrheal Microorganisms Market Share by Country (2021-2026) Table 206. Middle East and Africa Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East and Africa Antidiarrheal Microorganisms Market Share Forecast by Country (2027-2032) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Antidiarrheal Microorganisms Distributors List Table 211. Antidiarrheal Microorganisms Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Antidiarrheal Microorganisms Image Figure 2. Global Antidiarrheal Microorganisms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antidiarrheal Microorganisms Market Size (2021-2032) & (US$ Million) Figure 4. Global Antidiarrheal Microorganisms Sales (2021-2032) & (K Units) Figure 5. Bifidobacterium Live Bacteria Image Figure 6. Global Bifidobacterium Live Bacteria Sales YoY Growth (2021-2032) & (K Units) Figure 7. Bacillus Subtilis Live Bacteria Image Figure 8. Global Bacillus Subtilis Live Bacteria Sales YoY Growth (2021-2032) & (K Units) Figure 9. Bacillus Licheniformis Live Bacteria Image Figure 10. Global Bacillus Licheniformis Live Bacteria Sales YoY Growth (2021-2032) & (K Units) Figure 11. Other Image Figure 12. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Antidiarrheal Microorganisms Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Antidiarrheal Microorganisms Market Share by Type 2025 VS 2032 Figure 15. North America Antidiarrheal Microorganisms Sales Market Share in Volume by Type in 2025 Figure 16. North America Antidiarrheal Microorganisms Sales Market Share in Value by Type in 2025 Figure 17. Europe Antidiarrheal Microorganisms Sales Market Share in Volume by Type in 2025 Figure 18. Europe Antidiarrheal Microorganisms Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share in Value by Type in 2025 Figure 21. Latin America Antidiarrheal Microorganisms Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Antidiarrheal Microorganisms Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Antidiarrheal Microorganisms Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmacy Image Figure 28. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Antidiarrheal Microorganisms Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Antidiarrheal Microorganisms Market Share by Application 2025 VS 2032 Figure 37. North America Antidiarrheal Microorganisms Sales Market Share in Volume by Application in 2025 Figure 38. North America Antidiarrheal Microorganisms Sales Market Share in Value by Application in 2025 Figure 39. Europe Antidiarrheal Microorganisms Sales Market Share in Volume by Application in 2025 Figure 40. Europe Antidiarrheal Microorganisms Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Antidiarrheal Microorganisms Sales Market Share in Value by Application in 2025 Figure 43. Latin America Antidiarrheal Microorganisms Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Antidiarrheal Microorganisms Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Antidiarrheal Microorganisms Sales Market Share in Value by Application in 2025 Figure 47. North America Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Antidiarrheal Microorganisms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Antidiarrheal Microorganisms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Antidiarrheal Microorganisms Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Antidiarrheal Microorganisms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Antidiarrheal Microorganisms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Antidiarrheal Microorganisms Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Antidiarrheal Microorganisms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Antidiarrheal Microorganisms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Antidiarrheal Microorganisms Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Antidiarrheal Microorganisms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Antidiarrheal Microorganisms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Antidiarrheal Microorganisms Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Antidiarrheal Microorganisms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Antidiarrheal Microorganisms Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Antidiarrheal Microorganisms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Antidiarrheal Microorganisms Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Antidiarrheal Microorganisms Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Antidiarrheal Microorganisms Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Bifidobacterium Live Bacteria
  • Bacillus Subtilis Live Bacteria
  • Bacillus Licheniformis Live Bacteria
  • Other
Applications
  • Pharmacy
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhejiang Jingxin Pharmaceutical Co., Ltd.
  • Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  • Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
  • Livzon Pharmaceutical Factory of Livzon Group
  • Sinovac Biotech Co., Ltd.
  • Jincheng Haisi Pharmaceutical Co., Ltd.
  • Hangzhou Yuanda Biopharmaceutical Co., Ltd.
  • Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
  • Beijing Hanmei Pharmaceutical Co., Ltd.
  • VWR
  • Vermicon AG
  • Tangsonsbio
  • Pepto Bismol
  • Goerlich Pharma
  • Chr. Hansen
  • Biofermin
  • Aptalis Pharma SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antidiarrheal Microorganisms Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antidiarrheal Microorganisms Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antidiarrheal Microorganisms Market by Type
  6. 1.3.1 Bifidobacterium Live Bacteria
  7. 1.3.2 Bacillus Subtilis Live Bacteria
  8. 1.3.3 Bacillus Licheniformis Live Bacteria
  9. 1.3.4 Other
  10. 1.4 Global Antidiarrheal Microorganisms Market Size by Type
  11. 1.4.1 Global Antidiarrheal Microorganisms Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Antidiarrheal Microorganisms Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Antidiarrheal Microorganisms Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Antidiarrheal Microorganisms Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Antidiarrheal Microorganisms Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Antidiarrheal Microorganisms Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Antidiarrheal Microorganisms Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Antidiarrheal Microorganisms Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antidiarrheal Microorganisms Industry Trends
  2. 2.2 Antidiarrheal Microorganisms Industry Drivers
  3. 2.3 Antidiarrheal Microorganisms Industry Opportunities and Challenges
  4. 2.4 Antidiarrheal Microorganisms Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antidiarrheal Microorganisms Revenue (2021-2026)
  2. 3.2 Global Top Players by Antidiarrheal Microorganisms Sales (2021-2026)
  3. 3.3 Global Top Players by Antidiarrheal Microorganisms Price (2021-2026)
  4. 3.4 Global Antidiarrheal Microorganisms Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antidiarrheal Microorganisms Major Company Production Sites & Headquarters
  6. 3.6 Global Antidiarrheal Microorganisms Company, Product Type & Application
  7. 3.7 Global Antidiarrheal Microorganisms Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antidiarrheal Microorganisms Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antidiarrheal Microorganisms Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antidiarrheal Microorganisms Tier 1, Tier 2, and Tier 3
4 Antidiarrheal Microorganisms Regional Status and Outlook
  1. 4.1 Global Antidiarrheal Microorganisms Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antidiarrheal Microorganisms Historic Market Size by Region
  3. 4.2.1 Global Antidiarrheal Microorganisms Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antidiarrheal Microorganisms Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antidiarrheal Microorganisms Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antidiarrheal Microorganisms Forecasted Market Size by Region
  7. 4.3.1 Global Antidiarrheal Microorganisms Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antidiarrheal Microorganisms Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antidiarrheal Microorganisms Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antidiarrheal Microorganisms by Application
  1. 5.1 Antidiarrheal Microorganisms Market by Application
  2. 5.1.1 Pharmacy
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.1.4 Other
  6. 5.2 Global Antidiarrheal Microorganisms Market Size by Application
  7. 5.2.1 Global Antidiarrheal Microorganisms Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antidiarrheal Microorganisms Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antidiarrheal Microorganisms Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antidiarrheal Microorganisms Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antidiarrheal Microorganisms Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antidiarrheal Microorganisms Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antidiarrheal Microorganisms Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antidiarrheal Microorganisms Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Jingxin Pharmaceutical Co., Ltd.
  2. 6.1.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  6. 6.1.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
  8. 6.2.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  12. 6.2.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
  14. 6.3.1 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  18. 6.3.5 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Livzon Pharmaceutical Factory of Livzon Group
  20. 6.4.1 Livzon Pharmaceutical Factory of Livzon Group Company Information
  21. 6.4.2 Livzon Pharmaceutical Factory of Livzon Group Business Overview
  22. 6.4.3 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolio
  24. 6.4.5 Livzon Pharmaceutical Factory of Livzon Group Recent Developments
  25. 6.5 Sinovac Biotech Co., Ltd.
  26. 6.5.1 Sinovac Biotech Co., Ltd. Company Information
  27. 6.5.2 Sinovac Biotech Co., Ltd. Business Overview
  28. 6.5.3 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  30. 6.5.5 Sinovac Biotech Co., Ltd. Recent Developments
  31. 6.6 Jincheng Haisi Pharmaceutical Co., Ltd.
  32. 6.6.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  36. 6.6.5 Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Hangzhou Yuanda Biopharmaceutical Co., Ltd.
  38. 6.7.1 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  42. 6.7.5 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
  44. 6.8.1 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  48. 6.8.5 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Beijing Hanmei Pharmaceutical Co., Ltd.
  50. 6.9.1 Beijing Hanmei Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Beijing Hanmei Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
  54. 6.9.5 Beijing Hanmei Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 VWR
  56. 6.10.1 VWR Company Information
  57. 6.10.2 VWR Business Overview
  58. 6.10.3 VWR Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 VWR Antidiarrheal Microorganisms Product Portfolio
  60. 6.10.5 VWR Recent Developments
  61. 6.11 Vermicon AG
  62. 6.11.1 Vermicon AG Company Information
  63. 6.11.2 Vermicon AG Business Overview
  64. 6.11.3 Vermicon AG Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Vermicon AG Antidiarrheal Microorganisms Product Portfolio
  66. 6.11.5 Vermicon AG Recent Developments
  67. 6.12 Tangsonsbio
  68. 6.12.1 Tangsonsbio Company Information
  69. 6.12.2 Tangsonsbio Business Overview
  70. 6.12.3 Tangsonsbio Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Tangsonsbio Antidiarrheal Microorganisms Product Portfolio
  72. 6.12.5 Tangsonsbio Recent Developments
  73. 6.13 Pepto Bismol
  74. 6.13.1 Pepto Bismol Company Information
  75. 6.13.2 Pepto Bismol Business Overview
  76. 6.13.3 Pepto Bismol Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pepto Bismol Antidiarrheal Microorganisms Product Portfolio
  78. 6.13.5 Pepto Bismol Recent Developments
  79. 6.14 Goerlich Pharma
  80. 6.14.1 Goerlich Pharma Company Information
  81. 6.14.2 Goerlich Pharma Business Overview
  82. 6.14.3 Goerlich Pharma Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Goerlich Pharma Antidiarrheal Microorganisms Product Portfolio
  84. 6.14.5 Goerlich Pharma Recent Developments
  85. 6.15 Chr. Hansen
  86. 6.15.1 Chr. Hansen Company Information
  87. 6.15.2 Chr. Hansen Business Overview
  88. 6.15.3 Chr. Hansen Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Chr. Hansen Antidiarrheal Microorganisms Product Portfolio
  90. 6.15.5 Chr. Hansen Recent Developments
  91. 6.16 Biofermin
  92. 6.16.1 Biofermin Company Information
  93. 6.16.2 Biofermin Business Overview
  94. 6.16.3 Biofermin Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Biofermin Antidiarrheal Microorganisms Product Portfolio
  96. 6.16.5 Biofermin Recent Developments
  97. 6.17 Aptalis Pharma SAS
  98. 6.17.1 Aptalis Pharma SAS Company Information
  99. 6.17.2 Aptalis Pharma SAS Business Overview
  100. 6.17.3 Aptalis Pharma SAS Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolio
  102. 6.17.5 Aptalis Pharma SAS Recent Developments
7 North America by Country
  1. 7.1 North America Antidiarrheal Microorganisms Sales by Country
  2. 7.1.1 North America Antidiarrheal Microorganisms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antidiarrheal Microorganisms Sales by Country (2021-2026)
  4. 7.1.3 North America Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antidiarrheal Microorganisms Market Size by Country
  6. 7.2.1 North America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antidiarrheal Microorganisms Market Size by Country (2021-2026)
  8. 7.2.3 North America Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antidiarrheal Microorganisms Sales by Country
  2. 8.1.1 Europe Antidiarrheal Microorganisms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antidiarrheal Microorganisms Sales by Country (2021-2026)
  4. 8.1.3 Europe Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antidiarrheal Microorganisms Market Size by Country
  6. 8.2.1 Europe Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antidiarrheal Microorganisms Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antidiarrheal Microorganisms Sales by Country
  2. 9.1.1 Asia-Pacific Antidiarrheal Microorganisms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antidiarrheal Microorganisms Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antidiarrheal Microorganisms Market Size by Country
  6. 9.2.1 Asia-Pacific Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antidiarrheal Microorganisms Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antidiarrheal Microorganisms Sales by Country
  2. 10.1.1 South America Antidiarrheal Microorganisms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antidiarrheal Microorganisms Sales by Country (2021-2026)
  4. 10.1.3 South America Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antidiarrheal Microorganisms Market Size by Country
  6. 10.2.1 South America Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antidiarrheal Microorganisms Market Size by Country (2021-2026)
  8. 10.2.3 South America Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antidiarrheal Microorganisms Sales by Country
  2. 11.1.1 Middle East and Africa Antidiarrheal Microorganisms Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antidiarrheal Microorganisms Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antidiarrheal Microorganisms Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antidiarrheal Microorganisms Market Size by Country
  6. 11.2.1 Middle East and Africa Antidiarrheal Microorganisms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antidiarrheal Microorganisms Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antidiarrheal Microorganisms Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antidiarrheal Microorganisms Value Chain Analysis
  2. 12.1.1 Antidiarrheal Microorganisms Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antidiarrheal Microorganisms Production Mode & Process
  7. 12.2 Antidiarrheal Microorganisms Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antidiarrheal Microorganisms Distributors
  10. 12.2.3 Antidiarrheal Microorganisms Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst